🇺🇸

Broad Market

· daily

Global High-Priority Regulatory Events — September 09, 2026

The September 9, 2026 batch is dominated by a wave of SEBI recovery certificate corrigenda (8 filings) and Indian insolvency proceedings, creating a distinctly bearish regulatory and restructuring undercurrent. However, several high-value M&A events—the definitive buyout of Selectis Health, the SPAC merger filings for Daedalus/HubX and Blue Laser Fusion, and the completion of Barinthus Biotherapeutics' acquisition—provide clear positive catalysts. A critical portfolio-level insight emerges from the troubled Indian companies: the financial distress is not uniform, as Oswal Overseas' successful CIRP withdrawal at a 100% creditor vote contrasts sharply with Raja Bahadur International's worsening liquidity crisis (current liabilities 4x current assets) and contradictory public statements. The Barinthus delisting (Voluntary, post-acquisition) and TMC warrant expiration are procedurally neutral, while Iveda Solutions' second Nasdaq extension highlights a binary survival risk for micro-cap companies.

24 high priority 24 total filings
· daily

US SEC Filings Daily Market Digest — September 09, 2026

Today's digest reveals a bifurcated market with strong capital expenditure and M&A activity in industrial and energy sectors, contrasted by significant distress in small-cap and micro-cap companies. Key themes include a wave of transformative M&A in the REIT and biotech spaces, with the $8.1B IRT/Centerspace merger and the $2.5B Standard BioTools/Treeline deal highlighting a trend toward consolidation for scale and pipeline depth. Period-over-period data shows a clear divergence: large-cap industrials like Sunbelt Rentals (+11.2% revenue) and semiconductor firms like ASE Technology (+45.7% YoY) are posting robust growth, while several small-cap firms (C3.ai, GIVBUX, Destination XL) are experiencing revenue declines and cash burn. Insider activity is mixed, with a notable insider purchase at CarParts.com signaling confidence, while CEO selling at SentinelOne and a tax-related sale at Innovex warrant monitoring. The most critical developments include a major accounting restatement at Hallmark Venture Group, a going-private transaction for Selectis Health, and a potential Nasdaq delisting for Premium Catering, all of which demand immediate investor attention.

25 high priority 25 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 09, 2026

The overnight filing cycle from September 8-9, 2026, reveals a market dominated by significant insider selling, particularly concentrated in the technology sector, where Silver Lake entities executed a coordinated, multi-faceted sell-down of Dell Technologies Inc. shares totaling over $36 million across multiple filings. This aggressive disposition by a major director, combined with substantial sales at Cloudflare and Sandisk, signals potential sector rotation or profit-taking by sophisticated investors. Conversely, a notable insider buy at Enovis Corp and a director purchase at ASTROTECH Corp provide isolated bullish signals. The period also features transformative corporate actions, including the full acquisition of Selectis Health at a 90.93% tender success rate and the proposed de-SPAC merger of General Fusion with Spring Valley Acquisition Corp. III, alongside a high-risk delisting notice for Premium Catering. Financially, ASE Technology Holding Co., Ltd. reported exceptional growth with revenues surging 45.7% YoY, while VolitionRx faces severe dilution risks from covenant breaches and down-round adjustments. The overall sentiment is cautious, with a clear theme of cash extraction by insiders and a focus on capital returns through buybacks at Novo Nordisk and KT Corp.

35 high priority 15 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 08, 2026

The September 8, 2026, filings reveal a market heavily bifurcated between aggressive capital deployment in strategic M&A and deep distress in small-cap companies. The most significant themes are a wave of CHIPS Act-funded quantum computing investments (Rigetti, D-Wave) and transformative bank mergers (WaFd/EverBank, Eagle Financial/John Marshall), signaling a 'bigger is better' strategy in both tech and regional banking. Conversely, a cluster of micro-cap companies (Synergy CHC, Vivos Therapeutics, Aterian) are facing existential threats from bankruptcy, massive dilution, and Nasdaq delisting, highlighting a severe capital access crisis for weaker balance sheets. Insider activity is notably absent from the filings, but the sheer volume of officer changes (over 15) suggests broad corporate restructuring. The data shows a clear divergence: well-capitalized firms are pursuing growth via M&A and government grants, while cash-strapped entities are resorting to desperate financing measures, creating a 'flight to quality' environment.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 08, 2026

This digest covers 40 filings from September 8, 2026, with a heavy concentration on insolvency, M&A, and delisting events. A dominant theme is the surge in SPAC activity, with three separate business combination announcements (Navitas/Claros, Meshflow/HGP, NMP/Gibson Technical) and one termination (Cayson/Mango), signaling a potential revival in the SPAC market. The filings also reveal a cluster of bankruptcy and insolvency proceedings, including Synergy CHC's Chapter 11 filing and Sangamo Therapeutics' ongoing Chapter 11, alongside several Indian companies navigating the insolvency resolution process. A significant cybersecurity incident at Boston Scientific is expected to materially impact its Q3 and full-year 2026 results, while two companies (Aterian, Estrella Immunopharma) face Nasdaq delisting risks. A notable trend is the voluntary delisting of Cosan S.A. and Kraft Heinz from US exchanges, raising questions about the attractiveness of US listings for certain foreign and domestic issuers. The data also shows a clear pattern of asset sales and corporate simplification, as seen with Medalist Diversified REIT and International Stem Cell, both of which are reshaping their business profiles. Overall, the filings point to a market environment with high event risk, significant corporate restructuring, and a potential inflection point for SPAC activity.

40 high priority 40 total filings
· daily

US SEC Filings Daily Market Digest — September 08, 2026

Today's digest reveals a market bifurcated between aggressive capital structure maneuvers and significant corporate distress. The most dominant theme is the transformative $3.9 billion reverse merger between WaFd and EverBank, which will create a major regional banking player and is projected to deliver 29% EPS accretion for WaFd shareholders. However, this positive signal is counterbalanced by a wave of distress signals: Synergy CHC Corp filed for Chapter 11 bankruptcy, Cosan S.A. is voluntarily delisting from the NYSE, and Vivos Therapeutics is executing a highly dilutive debt-for-equity swap that will increase its share count by 52%. On the capital allocation front, we see a clear divergence—companies like Bilibili and Gilat Satellite are raising debt capital for growth, while Equinor continues its disciplined buyback program. Insider activity is sparse but notable, with UMC's CFO executing a large, neutral-position trade. The biotech sector shows a positive regulatory catalyst with Belite Bio's NDA submission in Japan, while the energy sector sees Pampa Energy gaining a favorable regulatory regime in Argentina. Overall, the day is characterized by high-conviction M&A, acute financial distress in small-caps, and strategic capital raises, demanding a selective, risk-aware approach.

15 high priority 35 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 08, 2026

The overnight filing cycle reveals a market bifurcated between aggressive corporate restructuring and cautious capital management. The most significant development is the $3.9 billion reverse merger between WaFd and EverBank, creating a regional banking powerhouse with projected 29% EPS accretion for WaFd shareholders, though the fixed exchange ratio (59.2% to EverBank) signals a control premium. Concurrently, a wave of dilutive capital raises is sweeping through micro-cap and pre-revenue companies: Ocean Power Technologies (OPTT) is conducting a best-efforts offering with no minimum, Vivos Therapeutics is executing a 52% dilutive debt-to-equity swap, and Indaptus Therapeutics has opened a $100 million ATM facility. On the positive side, Circle Internet Group's acquisition of Tazapay for its stablecoin infrastructure and Belite Bio's NDA submission in Japan under the Sakigake designation represent high-conviction growth plays. The period-over-period data from Holtec Nuclear shows a 5.8% revenue decline but a swing to profitability, while AMC Networks' $120 million settlement forced a 32% cut to its free cash flow guidance, highlighting the financial drag from legacy litigation. Insider activity is sparse but notable: United Microelectronics Corp's CFO executed a large, simultaneous acquisition and disposition of 1 million shares, a neutral signal that warrants monitoring for future intent. The overall theme is one of portfolio cleansing—companies are aggressively addressing balance sheet issues, settling legal overhangs, and positioning for strategic shifts, creating both deep value traps and asymmetric upside opportunities for discerning investors.

15 high priority 35 medium 50 total filings
· daily

Global High-Priority Regulatory Events — September 07, 2026

The September 7, 2026, filing batch reveals a concentrated wave of corporate distress and restructuring activity in the Indian market, with 5 of 11 filings directly related to insolvency proceedings under the IBC. The most critical development is a fresh default by **Infrastructure Leasing & Financial Services Limited (IL&FS)** on a USAID-guaranteed loan, underscoring the lingering systemic risk from its massive ₹18,567.53 crore debt pile, of which only 13% has been discharged. This is compounded by a significant procedural milestone at **Sun Granite Export Ltd**, where the Committee of Creditors has appointed a Resolution Professional, signaling an active and high-stakes CIRP. A notable pattern is the emergence of a complex, multi-entity merger scheme involving **Lodha Developers Limited** absorbing **Roselabs Finance** and **National Standard (India) Limited**, which, while procedural, represents a significant corporate reorganization. The overall sentiment is heavily negative, driven by defaults and insolvencies, with a materiality score of 9/10 for the two default events. The data shows no period-over-period revenue or margin trends, as the filings are event-driven rather than financial performance updates, but the sheer volume of insolvency-related filings (5) points to a potential acceleration in corporate stress resolution, likely impacting credit markets and investor sentiment toward Indian mid-cap and stressed assets.

11 high priority 11 total filings
· daily

US Material Events SEC 8-K Filings — September 04, 2026

The September 4, 2026, filing cycle reveals a market dominated by transformative M&A and restructuring, with several high-conviction deals closing. The most significant event is SoundHound AI's acquisition of LivePerson, creating a debt-free conversational AI giant targeting over $500M in revenue from an existing Fortune 100 customer base, a clear [BULLISH] signal for the AI sector. Concurrently, Flex Ltd. announced a $4.4 billion acquisition of EPC Power to capture AI data center demand, alongside plans to spin off its Cloud and Power Infrastructure segment, signaling a strategic pivot. On the negative side, a wave of auditor resignations and going-concern warnings (Regenerex Pharma, Katapult) and a high-risk, short-term bridge loan (Stewards, Inc.) highlight acute financial distress among smaller caps. The period also saw significant insider activity with a large inducement grant for a key executive at Helix Energy Solutions, and a notable reduction in authorized shares at LivePerson, confirming the going-private nature of the deal. Overall, the digest points to a bifurcated market where well-capitalized firms are aggressively consolidating for growth, while others face existential liquidity crises.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 04, 2026

The 38 filings for September 4, 2026, reveal a market landscape dominated by corporate restructuring, delistings, and strategic M&A, particularly within the SPAC and small-cap space. A significant cluster of companies are facing Nasdaq non-compliance, with **SCWorx Corp.**, **Arcadia Biosciences**, **Quince Therapeutics**, and **Pantages Capital** all receiving deficiency notices, highlighting acute financial distress and elevated delisting risk across micro-cap equities. The completion of major acquisitions, including **SoundHound AI's** purchase of **LivePerson** and the merger of **USA Rare Earth** with **Serra Verde**, signals a consolidation trend in high-growth tech and critical minerals sectors. Insider activity is limited in the filings, but capital allocation decisions, such as **VineBrook Homes Trust's** tender offer at a 37.4% discount to NAV and **Monroe Capital's** oversubscribed buyback, provide key signals on management's view of intrinsic value. The period-over-period data from **Hemadri Cements** shows a dramatic operational shutdown (zero revenue vs. ₹794.62 Lakh YoY), while the **Archer Aviation** warrant expiration on September 16 creates a time-sensitive catalyst for warrant holders. Overall, the digest points to a bifurcated market where well-capitalized acquirers are consolidating, while a growing number of smaller entities face existential threats from listing standards and liquidity crises.

38 high priority 38 total filings
· daily

US SEC Filings Daily Market Digest — September 04, 2026

Today's digest reveals a market bifurcated between aggressive corporate restructuring and cautious capital management. The most significant development is Flex Ltd.'s $4.4 billion acquisition of EPC Power, coupled with plans to spin off its Cloud and Power Infrastructure segment, signaling a major bet on AI data center infrastructure. This is contrasted by multiple distress signals: Nixxy, Inc. received a Nasdaq deficiency notice, ClearOne faces a going concern risk with only $0.7M cash, and Rent the Runway agreed to a $9M class action settlement. On the positive side, Ionis Pharmaceuticals received FDA approval for ZANVASTRO, the first treatment for Alexander disease, while ChargePoint showed operational improvement with revenue up 17.7% YoY and a narrowed net loss. Insider activity was mixed, with NatWest executives conducting routine sales and Sea Ltd's COO selling $1.22M in shares under a 10b5-1 plan. Capital allocation trends show a preference for M&A and spin-offs over buybacks, with News Corp being a notable exception with its ongoing $1B repurchase program. The overall theme is one of strategic pivots and financial prudence, with significant opportunities in biotech and AI infrastructure, but elevated risks in SPACs and pre-revenue companies.

21 high priority 29 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 04, 2026

Overnight SEC filings from September 3-4, 2026, reveal a market bifurcated between high-conviction insider selling in growth/biotech names and significant corporate actions (M&A, spin-offs, restructurings). The most critical development is the FDA approval of Ionis Pharmaceuticals' ZANVASTRO for Alexander disease, a landmark event for an ultra-rare disorder, though offset by a mixed financial picture. A wave of insider selling, particularly at Natera, Spyre Therapeutics, and Takeda, signals potential near-term tops in these high-flying names. Activist pressure is building at TransAct Technologies, while corporate restructuring dominates headlines with Flex's spin-off and The Trade Desk's 15% workforce reduction. The IPO litigation settlement at Rent the Runway and the de-registration of RE/MAX highlight ongoing post-IPO and M&A fallout. Overall, the data suggests a cautious tone from corporate insiders, offset by significant strategic catalysts in biotech and energy.

39 high priority 11 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 03, 2026

This Material Events Monitor digest covers 50 filings, predominantly 8-Ks, revealing a market heavily engaged in strategic transactions and leadership transitions. A clear theme is the aggressive pursuit of growth through M&A, with notable deals in financial services (Equity Bancshares acquiring Lincoln Bancorp), industrial distribution (Hillman Solutions buying Kanebridge), and specialty materials (Apogee Enterprises acquiring GroGlass). Concurrently, the SPAC market remains active but faces significant headwinds, with several entities (Andretti Acquisition Corp. II, Wintergreen Acquisition Corp.) securing short-term extensions and non-redemption agreements to avoid liquidation, highlighting a challenging environment for de-SPAC transactions. Leadership changes are widespread, with several high-profile CFO and C-suite appointments (T-Mobile, Albemarle, Passage BIO) signaling strategic pivots or succession planning. Financially, the digest shows a bifurcated market: high-growth software (Guidewire) and logistics (Radiant) companies are investing in leadership and capacity, while pre-revenue biotechs (NextCure) and distressed entities (SunPower, Faraday Future) are taking defensive actions like lease terminations and warrant cancellations to preserve capital. The overall sentiment is cautiously optimistic, with a focus on execution risk and the ability of companies to navigate integration and funding challenges.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 03, 2026

The 42 filings reviewed for September 3, 2026, reveal a high-stakes environment dominated by SPAC activity, regulatory enforcement, and corporate distress. A clear theme is the aggressive maneuvering by SPACs to secure funding and extend deadlines, with PlusAI's $800 million merger and Ribbon Acquisition's dilutive financing standing out as high-materiality events. The regulatory front is intense, with SEBI issuing enforcement orders for fraud and insolvency, while Nasdaq delisting actions against JFB Construction and National Healthcare Properties signal significant corporate failures. Period-over-period data is limited, but where available, it shows strong growth (e.g., Heranba's subsidiary Mikusu growing 20% YoY) and strategic capital deployment (e.g., Hillman Solutions' $315M acquisition). The overall sentiment is mixed, with pockets of opportunity in strategic M&A and turnarounds, but significant risks from regulatory actions, SPAC deadline pressures, and delisting threats. The most critical development is the wave of SPAC transactions, which could unlock value or lead to significant losses depending on execution and market reception.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — September 03, 2026

The September 3, 2026 filing set reveals a market bifurcated between aggressive capital deployment and fundamental operational strain. A clear theme is the surge in SPAC activity, with four major business combinations (DRC Medicine, Mkango Rare Earths, PlusAI, Remix Therapeutics) and associated complex financing structures, signaling a revival in the de-SPAC market but also introducing significant dilution risks for existing shareholders. Operationally, a mixed picture emerges: Planet Labs and Mama's Creations posted exceptional revenue growth (58% and 55% YoY, respectively), while Domo and Concrete Pumping showed revenue deceleration or mixed segment performance. Insider activity is notably absent from most filings, but a high-profile activist campaign at SkyAI (formerly Sharps Technology) and a substantial insider purchase at KLX Energy highlight governance and valuation debates. Capital allocation is a key theme, with major buyback programs from Toyota ($6.8B authorized) and ORIX ($1.7B authorized) signaling confidence, while News Corp and Bank of Montreal also pursue repurchases. The most critical developments include the $510M all-stock acquisition by Ming Shing Group, the $123.8M bank merger by Equity Bancshares, and the $72.5M European expansion by Apogee Enterprises. The overall market tone is cautiously optimistic, with growth in select tech and industrial names offset by persistent losses in pre-revenue biotech and SPAC entities.

22 high priority 28 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 03, 2026

This overnight filing cycle is dominated by a surge in SPAC activity, with four major business combination announcements (PlusAI, Remix Therapeutics, Ursa Major, Elroy Air) signaling a potential resurgence in the de-SPAC market. A significant capital allocation theme emerges from large-scale share repurchase programs at Toyota (JPY 1 trillion) and ORIX (¥250 billion), indicating strong corporate confidence in undervaluation. The biotech sector presents a stark contrast, with Passage BIO's cash-burning pre-revenue status and a major licensing deal between HUTCHMED and GSK, highlighting the sector's binary risk/reward profile. Insider selling is concentrated in the technology sector, with multiple executives at Rackspace Technology and RxSight reducing their holdings, which warrants caution. A notable related-party acquisition by Scienjoy Holding and a highly dilutive financing structure for Ribbon Acquisition Corp. present complex risk/reward scenarios for investors.

27 high priority 23 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 02, 2026

The September 2, 2026, filings reveal a market bifurcated between aggressive corporate action and underlying financial distress. A clear theme is the pursuit of growth through M&A, with large-cap industrial Vertiv ($1.45B deal for UIG) and smaller players like EVI Industries, cbdMD, and SPACs leading the charge, while G-III Apparel strengthens its portfolio via the Marc Jacobs acquisition. Countering this, a wave of financing events—from stock offerings (PMV Pharmaceuticals) and dilutive note agreements (Senti Biosciences, VolitionRx) to a significant SPAC deal termination (Quantumsphere Acquisition)—highlights acute capital constraints, particularly in the biotech and small-cap space. Operational results are mixed; Daktronics shows a 21% YoY EPS jump but a 20% YoY slump in new orders, signaling potential future revenue headwinds. A massive shakeup in leadership is also underway, with significant C-suite and board changes at major firms like Lowe's, Hershey, and AIG, alongside a wave of director resignations at smaller firms. The period-over-period data, where available, points to margin expansion for some (G-III's 440bps gross margin improvement) but growing stress in order books and balance sheets for others, suggesting investors should prioritize companies with strong operational momentum and clear, executable strategies over those relying on external financing for survival.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 02, 2026

This digest covers 48 filings from September 2, 2026, dominated by corporate distress signals (insolvencies, delistings, asset sales) and deal-making (M&A, SPAC activity, open offers). A key theme is the high failure rate of SPACs, with Quantumsphere Acquisition Corp terminating its merger and significant redemptions at D. Boral ARC Merger Corp (96% of public shares redeemed). The Indian market shows a surge in insolvency filings (Parsvnath, Astron Paper, Baron Infotech) and a notable failed open offer for Bliss GVS Pharma, where only 0.00% of the target shares were tendered. Conversely, there is active capital deployment in renewable energy (India Cements) and specialty chemicals (Fine Organic Industries), alongside several new SPAC IPOs raising over $395 million. The data reveals a bifurcated market: distressed entities are liquidating or restructuring, while well-capitalized firms pursue strategic acquisitions and growth investments.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — September 02, 2026

Today's digest (Sept 2, 2026) reveals a market bifurcated between aggressive growth investments and defensive capital returns. The standout theme is a massive, coordinated equity award to TSMC's top management, signaling strong retention and confidence in future execution, while Sea Ltd's C-suite selling under 10b5-1 plans provides a contrasting note of caution. In the SPAC and small-cap space, deal risk is elevated, with Quantumsphere's merger termination and Nuburu's 1-for-40 reverse split highlighting distress. On the positive side, Bitdeer's $100M land acquisition for AI/HPC infrastructure and GitLab's 21% revenue growth (despite widening losses) show capital being deployed for long-term growth. Capital returns are steady, with Vertiv declaring a dividend and News Corp continuing its $1B buyback. The overall picture is one of selective opportunity, with a clear preference for companies with strong secular tailwinds (AI, cloud, semiconductors) over those with uncertain deal outcomes or dilutive financing structures.

29 high priority 21 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 02, 2026

Overnight filings reveal a market bifurcated between aggressive insider buying at micro-cap biotech Quoin Pharmaceuticals and significant insider selling at high-growth industrials like Coherent and Standex, signaling divergent management conviction. The most material corporate event is the termination of the Quantumsphere Acquisition Corp. SPAC merger, a high-risk signal for the de-SPAC market. A notable sector theme is the concentrated insider buying in the biotech/pharma space, particularly at Quoin and Waste Energy, contrasting with routine insider selling for tax purposes at larger caps. Capital allocation is mixed, with Vertiv declaring a modest dividend while VolitionRx continues dilutive convertible note conversions. The Skyworks-Qorvo merger extension provides a key catalyst to monitor, while the HDFC Bank and ICICI Bank credit rating updates offer a positive signal for Indian financials. Overall, the data suggests a cautious market with selective, high-conviction bets in small-cap value and biotech, while large-cap tech and industrial insiders are reducing exposure.

34 high priority 16 medium 50 total filings